Activated complement factor 3 is associated with liver fat and liver enzymes: the CODAM study-Reference-Cited by-同舟云学术

Activated complement factor 3 is associated with liver fat and liver enzymes: the CODAM study

Published:2013-04-16 Issue:7 Volume:43 Page:679-688
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Wlazlo Nick,van Greevenbroek Marleen M. J.,Ferreira Isabel,Jansen Eugene H. J. M.¹,Feskens Edith J. M.²,van der Kallen Carla J. H.,Schalkwijk Casper G.,Bravenboer Bert³,Stehouwer Coen D. A.

Affiliation:

1. Laboratory of Health Protection Research; National Institute for Public Health and the Environment (RIVM); Bilthoven; the Netherlands

2. Division of Human Nutrition - Section Nutrition and Epidemiology; Wageningen University; Wageningen; the Netherlands

3. Department of Internal Medicine; Catharina Hospital; Eindhoven; the Netherlands

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/eci.12093/fullpdf

Reference33 articles.

1. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study;Bedogni;Hepatology,2005

2. High prevalence of diabetes mellitus in patients with liver cirrhosis;Wlazlo;Diabet Med,2010

3. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999

4. Alcoholic hepatitis;Lucey;N Engl J Med,2009

5. Cytokines in alcoholic and nonalcoholic steatohepatitis;Tilg;N Engl J Med,2000

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses;Biomedicine & Pharmacotherapy;2023-12

2. From complement to complosome in non‐alcoholic fatty liver disease: When location matters;Liver International;2023-11-27

3. Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease;Annual Review of Pathology: Mechanisms of Disease;2023-01-24

4. Association of complement components with the risk and severity of NAFLD: A systematic review and meta-analysis;Frontiers in Immunology;2022-12-07

5. Non-alcoholic fatty liver disease and liver secretome;Archives of Pharmacal Research;2022-11-28